Q-Line Biotech Limited

<table><thead><tr><th>Particulars of the Issue<sup>(2)</sup></th><th>Market Maker Reservation Portion</th><th>QIBs<sup>(1)</sup></th><th>Non-Institutional Investors</th><th>Individual Investors</th></tr></thead><tbody><tr><td></td><td></td><td>Up to [●] Equity Shares of face value of ₹10/- each shall be available for allocation on a proportionate basis to all QIBs, including Mutual Funds receiving allocation as per (a) above. Up to 60% of the QIB Portion (of up to [●] Equity Shares of face value of ₹10/- each may be allocated on a discretionary basis to Anchor Investors of which one-third shall be available for allocation to Mutual Funds only, subject to valid Bid received from Mutual Funds at or above the Anchor Investor Allocation Price</td><td>the remaining Equity Shares, if any, shall be allotted on a proportionate basis as follows –<br>One-third of the Non-Institutional Category will be made available for allocation to Bidders with an application size of more than two lots and up to such lots equivalent to not more than ₹10 lakhs.<br>Two-third of the Non-Institutional Category will be made available for allocation to Bidders with an application size of more than ₹1,000,000.<br>For details, see "Issue Procedure" beginning on page 344 of this Draft Red Herring Prospectus.<br>Provided that the unsubscribed portion in either of the aforementioned subcategories may be allocated to Non-Institutional Bidders in the other subcategory of Non-Institutional Bidders.</td><td>available Equity Shares if any, shall be allotted on proportionate basis. For details, see "Issue Procedure" beginning on page 344 of this Draft Red Herring Prospectus.</td></tr><tr><td>Mode of Allotment</td><td colspan="4">Compulsorily in dematerialized form.</td></tr><tr><td>Minimum Bid Size</td><td>[●] Equity Shares of face value of ₹10/- each</td><td>Such number of Equity Shares and in multiples of [●] Equity Shares of face value of ₹10/- each that the Bid exceeds two lots</td><td>Such number of Equity Shares and in multiples of [●] Equity Shares of face value of ₹10/- each that the Bid exceeds two lots</td><td>Two lots with minimum application size of above Rs 2 lakhs</td></tr><tr><td>Maximum Bid Size</td><td>[●] Equity Shares of face value of ₹10/- each</td><td>Such number of Equity Shares in multiples of [●] Equity Shares of face value of ₹10/- each not exceeding the size of the Net Issue, subject to applicable limits</td><td>Such number of Equity Shares in multiples of [●] Equity Shares of face value of ₹10/- each not exceeding the size of the Net Issue (excluding the QIB portion), subject to applicable limits</td><td>Two lots with minimum application size of above Rs 2 lakhs</td></tr><tr><td>Trading Lot</td><td>[●] Equity Shares of face value of ₹10/- each, However the Market Maker may accept odd lots if any in the market as required under the SEBI (ICDR) Regulations, 2018.</td><td>[●] Equity Shares of face value of ₹10/- each and in multiples thereof</td><td>[●] Equity Shares of face value of ₹10/- each and in multiples thereof</td><td>[●] Equity Shares of face value of ₹10/- each and in multiples thereof</td></tr><tr><td>Terms of Payment</td><td colspan="4">Full Bid Amount shall be blocked by the SCSBs in the bank account of the ASBA Bidder (other than Anchor Investors) or by the Sponsor Bank through the UPI Mechanism, that is specified in the ASBA Form at the</td></tr></tbody></table>

341